UK partnership set to revolutionise oligonucleotide manufacture
CPI, AstraZeneca, Novartis, and The University of Manchester will collaborate to facilitate large-scale manufacture of oligonucleotides.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
